Medroxyprogesterone acetate alters mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Kleynhans, Léanie ^a   du Plessis, Nelita ^a   Black, Gillian F ^a   Loxton, André G ^a   Kidd, Martin ^b   van Helden, Paul D ^a   Walzl, Gerhard ^a   Ronacher, Katharina ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD40 LIGAND; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; STEROID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADOLESCENT; ADULT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; GENE REPRESSION; GENITAL TRACT INFECTION; HORMONE DETERMINATION; HUMAN; IC 50; IMMUNOLOGICAL MEMORY; IN VITRO STUDY; MONOCYTE; MYCOBACTERIUM BOVIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN SYNTHESIS INHIBITION; TUBERCULOSIS; UPREGULATION; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL;

MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-13; LEUKOCYTES, MONONUCLEAR; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; MYCOBACTERIUM BOVIS; YOUNG ADULT;

EID: 80052520732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024639     Document Type: Article

References (45)

1. World Health Organization (2008) Global Health Observatory (GHO) TB incidence Available: http://www.who.int/gho/mdg/diseases/tuberculosis/situation_trends_incidence/en/index.html. Accessed 2010 Nov 19.
2. Biondi M, Zannino LG, (1997) Psychological stress, neuroimmunomodulation, and susceptibility to infectious diseases in animals and man: a review. Psychother Psychosom 66: 3-26.
3. Howard AD, Zwilling BS, (1999) Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines. Clin Exp Immunol 115: 428-434.
4. Manabe YC, Kesavan AK, Lopez-Molina J, Hatem CL, Brooks M, et al. (2008) The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome. Tuberculosis(Edinb) 88: 187-196.
5. Scanga CA, Mohan VP, Joseph H, Yu K, Chan J, et al. (1999) Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect Immun 67: 4531-4538.
6. Jick SS, Lieberman ES, Rahman MU, Choi HK, (2006) Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 55: 19-26.
7. Mahuad C, Bay ML, Farroni MA, Bozza V, del Rey A, et al. (2004) Cortisol and dehydroepiandrosterone affect the response of peripheral blood mononuclear cells to mycobacterial antigens during tuberculosis. Scand J Immunol 60: 639-646.
8. Kontula K, Paavonen T, Luukkainen T, Andersson LC, (1983) Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol 32: 1511-1518.
9. Koubovec D, Ronacher K, Stubsrud E, Louw A, Hapgood JP, (2005) Synthetic progestins used in HRT have different glucocorticoid agonist properties. Mol Cell Endocrinol 242: 23-32.
10. Trunova N, Tsai L, Tung S, Schneider E, Harouse J, et al. (2006) Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology 352: 169-177.
11. Kaushic C, Ashkar AA, Reid LA, Rosenthal KL, (2003) Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J Virol 77: 4558-4565.
12. Mostad SB, Kreiss JK, Ryncarz AJ, Mandaliya K, Chohan B, et al. (2000) Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency. J Infect Dis 181: 58-63.
13. Mostad SB, Overbaugh J, DeVange DM, Welch MJ, Chohan B, et al. (1997) Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 350: 922-927.
14. Overton ET, Shacham E, Singhatiraj E, Nurutdinova D, (2008) Incidence of sexually transmitted infections among HIV-infected women using depot medroxyprogesterone acetate contraception. Contraception 78: 125-130.
15. Leclerc PM, Dubois-Colas N, Garenne M, (2008) Hormonal contraception and HIV prevalence in four African countries. Contraception 77: 371-376.
16. Myer L, Denny L, Wright TC, Kuhn L, (2007) Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol 36: 166-174.
17. Pettifor A, Delany S, Kleinschmidt I, Miller WC, Atashili J, et al. (2009) Use of injectable progestin contraception and risk of STI among South African women. Contraception 80: 555-560.
18. Morrison CS, Chen PL, Kwok C, Richardson BA, Chipato T, et al. (2010) Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 24: 1778-1781.
19. Morrison CS, Chen PL, Nankya I, Rinaldi A, Van Der PB, et al. (2011) Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe. J Acquir Immune Defic Syndr 57: 157-164.
20. Back DJ, Orme ML, (1990) Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet 18: 472-484.
21. Black GF, Fine PEM, Warndorff DK, Floyd S, Weir RE, et al. (2001) Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Int J Tuberc Lung Dis 5: 664-72.
22. Fang S, Sun D, Jiang H, Luo H, (2004) Concentration changes if medroxyprogesterone acetate in serum and milk in lactating women who used depo geston. J Reprod Contraception 15: 157-162.
23. Jeppsson S, Gershagen S, Johansson ED, Rannevik G, (1982) Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Acta Endocrinol(Copenh) 99: 339-343.
24. Ortiz A, Hirol M, Stanczyk FZ, Goebelsmann U, Mishell DR, (1977) Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA. J Clin Endocrinol Metab 44: 32-38.
25. Shi L, Jung YJ, Tyagi S, Gennaro ML, North RJ, (2003) Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proc Natl Acad Sci USA 100: 241-246.
26. Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, et al. (1999) Depo Provera. Position paper on clinical use, effectiveness and side effects. Br J Fam Plann 25: 69-76.
27. Elenkov IJ, (2004) Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci 1024: 138-46.
28. Liu Z, Yuan X, Luo Y, He Y, Jiang Y, et al. (2009) Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood. Cytokine 45: 141-7.
29. Liberman AC, Refojo D, Druker J, Toscano M, Rein T, et al. (2007) The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J 21: 1177-88.
30. Maneechotesuwan K, Yao X, Ito K, Jazrawi E, Usmani OS, et al. (2009) Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease. PLoSMed 6: e1000076.
31. Unterberger C, Staples KJ, Smallie T, Williams L, Foxwell B, et al. (2008) Role of STAT3 in glucocorticoid-induced expression of the human IL-10 gene. Mol Immunol 45: 3230-3237.
32. Smoak KA, Cidlowski JA, (2004) Mechanisms of glucocorticoid receptor signaling during inflammation. Mech Ageing Dev 125: 697-706.
33. Bamberger CM, Else T, Bamberger AM, Beil FU, Schulte HM, (1999) Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes. J Clin Endocrinol Metab 84: 4055-4061.
34. Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, et al. (1995) The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84: 423-432.
35. Cooper AM, Magram J, Ferrante J, Orme IM, (1997) Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J Exp Med 186: 39-45.
36. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, et al. (1993) Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177: 1199-1204.
37. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, et al. (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170: 827-845.
38. Cooper AM, Kipnis A, Turner J, Magram J, Ferrante J, et al. (2002) Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J Immunol 168: 1322-1327.
39. Juffermans NP, Florquin S, Camoglio L, Verbon A, Kolk AH, et al. (2000) Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis 182: 902-908.
40. Sugawara I, Yamada H, Hua S, Mizuno S, (2001) Role of interleukin (IL)-1 type 1 receptor in mycobacterial infection. Microbiol Immunol 45: 743-750.
41. D'Andrea A, ste-Amezaga M, Valiante NM, Ma X, Kubin M, et al. (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178: 1041-1048.
42. Powrie F, Coffman RL, (1993) Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 14: 270-274.
43. Redford PS, Boonstra A, Read S, Pitt J, Graham C, et al. (2010) Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur J Immunol 40: 2200-2210.
44. Higgins DM, Sanchez-Campillo J, Rosas-Taraco AG, Lee EJ, Orme IM, et al. (2009) Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis(Edinb) 89: 149-157.
45. Heimbeck I, Hofer TP, Eder C, Wright AK, Frankenberger M, et al. (2010) Standardized single-platform assay for human monocyte subpopulations: Lower CD14+CD16++ monocytes in females. Cytometry A 77: 823-830.